Catalyst

Slingshot members are tracking this event:

Janssen (JNJ) Submits Marketing Application in Japan for Darzalex in Multiple Myeloma

Source Link:
http://seekingalpha.com/pr/16697802-genmab-announces-submission-regulatory-application-daratumumab-relapsed-refractory-multiple

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
JNJ
100%
GNMSF
100%
SIGN ME UP
I want to vote! LOG ME IN
Now!
Slingshot Insights Explained
JOIN FOR FREE TODAY
Catalyst Date
Occurred on:
Dec 20, 2016
Related Projects Image

  • Don’t see a project related to the catalyst you care about?

Related Keywords Marketing Application, Darzalex, Multiple Myeloma
About Us
Media Center
Connect with Us
© 2024 Slingshot Insights. All rights reserved.